08 Watson Replication 2
08 Watson Replication 2
DNA duplication
prokariotes, eukariotes,
(initiation, elongation, termination)
DNA/RNA transcription
eukariotes, prokariotes
(initiation, elongation, termination)
RNA/protein translation
eukariotes, prokariotes
(initiation, elongation, termination)
Genetic code
mRNA processing
(capping, splicing, poli A addition)
Regulation of transcription in
prokariotes
Regulation of transcription in
eukariotes
Epigenetics
Regulatory RNAs
Homologous recombination
Site specific recombination
The Meselson-Stahl
experiment.
Original
DNA
First
replication
Second
replication
dNTPs
a particular arrangement of primer and template called
primer: template junction
DNA synthesis is initiated when the 3’-OH of the primer mediates the
nucleophilic attack of the -phosphate of the incoming dNTP.
This results is the extension of the primer and the release of
pyrophosphate
The DNA polymerase monitors the ability of the incoming nucleotide to form a
correct A:T or G:C base pair
Contribution of
base-pair
geometry to the
fidelity of DNA
replication
An example of error
correction by the 3′→5′
exonuclease activity of
DNA polymerase I
Increased
affinity of
ssDNA for
exonuclease
site
The bound DNA lies on the palm domain: the active site
The fingers domain contains the dNTPs binding site and the
catalytic site is located between the fingers and the thumb
Holds primer
DNA POL I template in
active site in
dNTP polimerase
binding
site Active site
Catalitic Controls correct
base pairing
site
Single strand DNA region is
bent sharply and does not
pass between thumb and
fingers
Only one base is exposed in
catalitic site
Once the correct base pair is formed, the fingers domain moves to
enclose dNTP (it grips the dNTP and it moves it in close contact with
the catalytic site).
After the bond with the new nucleotide is formed, the fingers opens up
and polymerase moves by one pair on the template
DNA Pol bound to DNA
Finger and tumb are
composed of alpha helices
incoming dNTP
template
primer
Palm domain is
composed of beta
sheets
Two metal ions bound to DNA polymerase catalyze
nucleotide addition
The two metal ions (shown in
green) are held
in place by interactions with two
highly conserved aspartate
residues.
Metal ion A primarily interacts
with the 3’-OH, resulting in
reduced association between the
O and the H. This leaves a
nucleophilic 3’O-.
Incoming
nucleotide
The bent template strand exposes only one base in the
catalytic site: the template base
Single strand
DNA region is
bent sharply
and does not
pass between
thumb and
fingers
Only one base
is exposed in
catalitic site
DNA polymerases synthesize DNA in a processive manner
Replication fork
DNA synthesis
continues until the
Okazaki fragment
extends as far as the
primer of the previously
added Okazaki
fragment.
A new primer is
synthesized near the
replication fork to begin
the process again
Binding of SSB protein to DNA is cooperative
from 3-200nt
till 500000 nt
Sliding clamps from E.coli, T4, Eukariotes
PCNA
Composition of the DNA polII enzyme (E.Coli)
Holoenzyme
is made up
the clamp loader, a
by 9-10 pentameric complex
subunits of that uses ATP to open
different type and close the clamp
around DNA
DNA polymerase III (E.Coli)
Primase
Helicase (dnaB) interacts
with Polimerase III
through subunits.
This interaction increases
helicase rate 10 fold
13 polimerases in total
4 DNA duplication
9 repair
08_Figure22.jpg
In the lagging strand, as the helicase unwinds it , DNA is
spooled out as single strand, looped and bound to SSB
Loading of sliding
clamp (blue ring)
Loading of sliding
clamp (blue ring)
Another mechanism
utilized to remove
resistant RNA primers
on lagging strand
DNA polymerase III Synthesys of
short rRNA
Primase primers
Helicase (dnaB) interacts with
Polimerase III through subunits.
This interaction increases
helicase rate 10 fold
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Origin of replication in E.coli, the virus SV40 and the
yeast S.cerevisiae
lagging leading
leading lagging
Model E. Coli initiation of replication (step g)
lagging
lagging
13 polimerases in total
4 DNA duplication
9 repair
DNA polymerase switching during eukaryotic DNA replication
Chromosome breakage as a results of incomplete DNA
replication during S phase of the cell cycle
Eukariotic chromosomes have each many origins of
replication
In eukaryotes
polymerases are slow:
only 30-50 nt/s
compared to 800-1000
bp/s from bacteria, but
there are many origins
of replication (>25,000)
spaced 30-300Kb apart,
+ pol IV and pol V for repair
In eukariotes replicators are inactivated by DNA
replication (no replicator can initiate after it has been
replicated)
ATP hydrolysis
is required
loading activation
In eukariotes elicases (MCM2) are loaded in G1 phase but
they stay inactive till activation in S phase by CCKs
No place for
a primer
5′
3′
3′
5′
3′
T T A GGG T T A GGG T T A GGG T T A GGG T T A GGG T T A GGG T T A GGG T T A GGG T T A GGG T T A GGG
AA AA AA AA AA AA AA AA
TCCC TCCC TCCC TCCC TCCC TCCC TCCC T
5′
Overhang
Repeat unit
T T A G G GT T A GG G T T A G GG T TA G G G 3
The binding- CA AU C
polymerization- A A T C C CAA T
RNA
Step 1 Binding
translocation cycle Telomerase synthesizes
3′ 5′
T T A G G GT T A GG G T T A G GG T T A G G GT T A G
CAAU C Step 2 Polymerization
A A T C C CAA T
Telomerase moves 6
This greatly nucleotides to the right and
begins to make another repeat.
lengthens one of T
T
Step 3 Translocation
the strands T T A G G GT T A GG G T T A G GG T T A G G GT T A G G G
CA A U C
A A T C C CAA T
The complementary
strand is made by primase,
DNA polymerase, and ligase.
T T A G G G T T A G G G T T A G G G T T A G G G T T A G G G T T A G G G 3′
The end is now
A A T C C C A A T C C C A A T C C C A A T C C C A A U C C C A A U 5’ lengthened
RNA primer
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
08_Figure37.jpg
repeat
08_Figure38.jpg
Telomers isolated from young people is longer
than that isolated from older people
Block human
topoisomerase I
Anticancer drugs
Camptothecin
Block human
topoisomerase II
Anticancer
drugs
SIDE EFFECTS OF CHEMIOTHERAPY